Midway through trading Friday, the Dow traded down 2.01% to 25227.54 while the NASDAQ fell 1.45% to 9872.13. The S&P also fell, dropping 1.61% to 3,034.01.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 2,422,310 cases with around 124,410 deaths. Brazil confirmed a total of over 1,228,110 COVID-19 cases with 54,970 deaths, while Russia reported a total of at least 619,930 confirmed cases and 8,770 deaths. In total, there were at least 9,628,650 cases of COVID-19 worldwide with over 489,730 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Real estate shares slipped by just 0.3% on Friday. Meanwhile, top gainers in the sector included Altisource Portfolio Solutions S.A. ASPS 8.79%, up 6%, and Phoenix Tree Holdings Limited DNK, up 5%.

In trading on Friday, financial shares fell 3.8%.

Top Headline

Nike Inc NKE 5.93% reported a loss for its fourth quarter on Thursday.

Nike posted a quarterly loss of $790 million, or $0.51 per share, versus a year-earlier profit of $989 million, or $0.62 per share. Its sales tumbled to $6.3 billion from $10.1 billion. Analysts expected sales of $7.3 billion.

Equities Trading UP

Vaxart, Inc. VXRT 60.38% shares shot up 59% to $9.95 after two announcements tied to coronavirus vaccine development. The South San Francisco, California-based company said its oral COVID-19 vaccine has been selected to participate in a non-human primate challenge study, or animal study, organized and funded by Operation Warp Speed. On Thursday, Vaxart said it signed a memorandum of understanding with Attwill Medical Solutions Sterilflow that will enable the latter to provide lyophilization development and large-scale manufacturing, including tableting and enteric coating, for Vaxart's COVID-19 vaccine.

Shares of MDC Partners Inc. MDCA 92.17% got a boost, shooting 109% to $2.4050 after the company announced the formation of a special committee to evaluate potential business combination with Stagwell.

Citius Pharmaceuticals, Inc. CTXR 34.26% shares were also up, gaining 40% to $1.51 after the company received an FDA response on its pre-investigational NDA for induced mesenchymal stem cells to treat acute respiratory distress syndrome in patients with coronavirus.

Equities Trading DOWN

Luckin Coffee Inc. LK 48% shares tumbled 52% to $1.44 after the company announced the withdrawal of its request for a Nasdaq hearing. The company's shares will be suspended at the open of business on June 29.

Shares of Seanergy Maritime Holdings Corp. SHIP 39.07% were down 37% to $0.1777 after the company reported downbeat Q1 results.

Recon Technology, Ltd. RCON 39.74% was down, falling 37% to $1.14 after the company reported pricing of $2.1 million registered direct offering.

Commodities

In commodity news, oil traded down 2% to $37.96, while gold traded up 0.1% to $1,772.90.

Silver traded down 0.7% Friday to $17.765, while copper rose 0.1% to $2.663.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.3%, the Spanish Ibex Index fell 1.3%, while Italy’s FTSE MIB Index dropped 0.4%. Meanwhile, the German DAX 30 slipped 0.6%, French CAC 40 slipped 0.1% and UK shares rose 0.4%.

Economics

US personal spending rose 8.2% in May, while personal income fell 4.2% in May.

The University of Michigan's consumer sentiment index declined to 78.1 in June, versus a preliminary reading of 78.9.

The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.

Benzinga does not provide investment advice. All rights reserved.

Recommended Content


Recommended Content

Editors’ Picks

EUR/USD clings to gains near 1.0700, awaits key US data

EUR/USD clings to gains near 1.0700, awaits key US data

EUR/USD clings to gains near the 1.0700 level in early Europe on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data. 

EUR/USD News

USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data

USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data

USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, recapturing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming intervention risks. The focus shifts to Thursday's US GDP report and the BoJ decision on Friday. 

USD/JPY News

Gold price lacks firm intraday direction, holds steady above $2,300 ahead of US data

Gold price lacks firm intraday direction, holds steady above $2,300 ahead of US data

Gold price remains confined in a narrow band for the second straight day on Thursday. Reduced Fed rate cut bets and a positive risk tone cap the upside for the commodity. Traders now await key US macro data before positioning for the near-term trajectory.

Gold News

Injective price weakness persists despite over 5.9 million INJ tokens burned

Injective price weakness persists despite over 5.9 million INJ tokens burned

Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price. Coupled with broader market gloom, INJ token’s doomed days may not be over yet.

Read more

Meta takes a guidance slide amidst the battle between yields and earnings

Meta takes a guidance slide amidst the battle between yields and earnings

Meta's disappointing outlook cast doubt on whether the market's enthusiasm for artificial intelligence. Investors now brace for significant macroeconomic challenges ahead, particularly with the release of first-quarter gross domestic product (GDP) data on Thursday.

Read more

Majors

Cryptocurrencies

Signatures